Dear Colleague,
We are delighted to share with you the highlights of Volume 2 of the Journal of Alzheimer's Disease Reports (JADR). Launched in 2017 as a sister to the Journal of Alzheimer’s Disease (JAD), JADR is an online-only, fully open access journal that gives equal weight to original research in basic science, translational research and clinical studies. It is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer's disease (AD).
The editorial leadership of both JADR and JAD work closely together to provide the AD community with greater and faster access to the breadth and depth of relevant content. We encourage direct submissions to Journal of Alzheimer's Disease Reports, taking advantage of the open access option and accelerated publication timeline (see instructions here).
All accepted papers are subject to payment of an Open Access Fee.
Until the end of 2018, this is set at the 50% reduced prices of $725 / EUR690.
As a member of our research community, we would like to invite you to contribute your own research articles to the journal. Contributing authors benefit from:
• First class Editorial Board (see below)
• Rigorous peer review and speedy manuscript processing
• Rapid online publication (pre-press)
• Openly available to all readers
• Open Access fees are reduced by 50% for papers submitted before the end of 2018
Submit your manuscript electronically
View detailed Instructions to Authors
Aims & Scope
I look forward to working with you.
Best regards,
Editor-in-Chief
George Perry, PhD
College of Sciences
University of Texas at San Antonio, USA
Email: george.perry@utsa.edu
Associate Editors
J. Wesson Ashford, MD, PhD, Stanford School of Medicine, USA
Craig S. Atwood, PhD, University of Wisconsin-Madison, USA
Jesús Ávila, MD, Universidad Autónoma de Madrid, Spain
Rudy Castellani, MD, University of Maryland, USA
Sergio Ferreira, PhD, Federal University of Rio de Janeiro, Brazil
Robert Friedland, MD, University of Louisville, USA
Daniela Galimberti, PhD, University of Milan, Italy
Alan Lerner, MD, Case Western Reserve University, USA
Ricardo Maccioni, PhD, International Center for Biomedicine, Chile
Patrizia Mecocci, MD, PhD, University of Perugia, Italy
Paula Moreira, PhD, University of Coimbra, Portugal
Akihiko Nunomura, MD, PhD, University of Yamanashi, Japan
Giulio Maria Pasinetti, MD, PhD, Mount Sinai School of Medicine, USA
Marwan N. Sabbagh, MD, Barrow Neurological Institute, USA
Thomas B. Shea, PhD, University of Massachusetts Lowell, USA
Massimo Tabaton, MD, University of Genova, Italy
Xiongwei Zhu, PhD, Case Western Reserve University, USA
